Morpholine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Morpholine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Morpholine industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Morpholine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Morpholine worldwide and market share by regions, with company and product introduction, position in the Morpholine market
Market status and development trend of Morpholine by types and applications
Cost and profit status of Morpholine, and marketing status
Market growth drivers and challenges
The report segments the global Morpholine market as:
Global Morpholine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Morpholine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Purity 97%
Purity 98%
Purity 98.5%
Other
Global Morpholine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemical Reagents
Pharmaceutical Intermediates
Other
Global Morpholine Market: Manufacturers Segment Analysis (Company and Product introduction, Morpholine Sales Volume, Revenue, Price and Gross Margin):
APL (IN)
Anhui Haoyuan (CN)
FUYUAN (CN)
Liaoyuan (CN)
Sinochem (CN)
Huntsman (US)
Basf (DE)
Nippon Nyukazai (JP)
Balaji Amines (IN)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Morpholine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Morpholine industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Morpholine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Morpholine worldwide and market share by regions, with company and product introduction, position in the Morpholine market
Market status and development trend of Morpholine by types and applications
Cost and profit status of Morpholine, and marketing status
Market growth drivers and challenges
The report segments the global Morpholine market as:
Global Morpholine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Morpholine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Purity 97%
Purity 98%
Purity 98.5%
Other
Global Morpholine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Chemical Reagents
Pharmaceutical Intermediates
Other
Global Morpholine Market: Manufacturers Segment Analysis (Company and Product introduction, Morpholine Sales Volume, Revenue, Price and Gross Margin):
APL (IN)
Anhui Haoyuan (CN)
FUYUAN (CN)
Liaoyuan (CN)
Sinochem (CN)
Huntsman (US)
Basf (DE)
Nippon Nyukazai (JP)
Balaji Amines (IN)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MORPHOLINE
1.1 Definition of Morpholine in This Report
1.2 Commercial Types of Morpholine
1.2.1 Purity 97%
1.2.2 Purity 98%
1.2.3 Purity 98.5%
1.2.4 Other
1.3 Downstream Application of Morpholine
1.3.1 Chemical Reagents
1.3.2 Pharmaceutical Intermediates
1.3.3 Other
1.4 Development History of Morpholine
1.5 Market Status and Trend of Morpholine 2013-2023
1.5.1 Global Morpholine Market Status and Trend 2013-2023
1.5.2 Regional Morpholine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Morpholine 2013-2017
2.2 Sales Market of Morpholine by Regions
2.2.1 Sales Volume of Morpholine by Regions
2.2.2 Sales Value of Morpholine by Regions
2.3 Production Market of Morpholine by Regions
2.4 Global Market Forecast of Morpholine 2018-2023
2.4.1 Global Market Forecast of Morpholine 2018-2023
2.4.2 Market Forecast of Morpholine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Morpholine by Types
3.2 Sales Value of Morpholine by Types
3.3 Market Forecast of Morpholine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Morpholine by Downstream Industry
4.2 Global Market Forecast of Morpholine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Morpholine Market Status by Countries
5.1.1 North America Morpholine Sales by Countries (2013-2017)
5.1.2 North America Morpholine Revenue by Countries (2013-2017)
5.1.3 United States Morpholine Market Status (2013-2017)
5.1.4 Canada Morpholine Market Status (2013-2017)
5.1.5 Mexico Morpholine Market Status (2013-2017)
5.2 North America Morpholine Market Status by Manufacturers
5.3 North America Morpholine Market Status by Type (2013-2017)
5.3.1 North America Morpholine Sales by Type (2013-2017)
5.3.2 North America Morpholine Revenue by Type (2013-2017)
5.4 North America Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Morpholine Market Status by Countries
6.1.1 Europe Morpholine Sales by Countries (2013-2017)
6.1.2 Europe Morpholine Revenue by Countries (2013-2017)
6.1.3 Germany Morpholine Market Status (2013-2017)
6.1.4 UK Morpholine Market Status (2013-2017)
6.1.5 France Morpholine Market Status (2013-2017)
6.1.6 Italy Morpholine Market Status (2013-2017)
6.1.7 Russia Morpholine Market Status (2013-2017)
6.1.8 Spain Morpholine Market Status (2013-2017)
6.1.9 Benelux Morpholine Market Status (2013-2017)
6.2 Europe Morpholine Market Status by Manufacturers
6.3 Europe Morpholine Market Status by Type (2013-2017)
6.3.1 Europe Morpholine Sales by Type (2013-2017)
6.3.2 Europe Morpholine Revenue by Type (2013-2017)
6.4 Europe Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Morpholine Market Status by Countries
7.1.1 Asia Pacific Morpholine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Morpholine Revenue by Countries (2013-2017)
7.1.3 China Morpholine Market Status (2013-2017)
7.1.4 Japan Morpholine Market Status (2013-2017)
7.1.5 India Morpholine Market Status (2013-2017)
7.1.6 Southeast Asia Morpholine Market Status (2013-2017)
7.1.7 Australia Morpholine Market Status (2013-2017)
7.2 Asia Pacific Morpholine Market Status by Manufacturers
7.3 Asia Pacific Morpholine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Morpholine Sales by Type (2013-2017)
7.3.2 Asia Pacific Morpholine Revenue by Type (2013-2017)
7.4 Asia Pacific Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Morpholine Market Status by Countries
8.1.1 Latin America Morpholine Sales by Countries (2013-2017)
8.1.2 Latin America Morpholine Revenue by Countries (2013-2017)
8.1.3 Brazil Morpholine Market Status (2013-2017)
8.1.4 Argentina Morpholine Market Status (2013-2017)
8.1.5 Colombia Morpholine Market Status (2013-2017)
8.2 Latin America Morpholine Market Status by Manufacturers
8.3 Latin America Morpholine Market Status by Type (2013-2017)
8.3.1 Latin America Morpholine Sales by Type (2013-2017)
8.3.2 Latin America Morpholine Revenue by Type (2013-2017)
8.4 Latin America Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Morpholine Market Status by Countries
9.1.1 Middle East and Africa Morpholine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Morpholine Revenue by Countries (2013-2017)
9.1.3 Middle East Morpholine Market Status (2013-2017)
9.1.4 Africa Morpholine Market Status (2013-2017)
9.2 Middle East and Africa Morpholine Market Status by Manufacturers
9.3 Middle East and Africa Morpholine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Morpholine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Morpholine Revenue by Type (2013-2017)
9.4 Middle East and Africa Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MORPHOLINE
10.1 Global Economy Situation and Trend Overview
10.2 Morpholine Downstream Industry Situation and Trend Overview
CHAPTER 11 MORPHOLINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Morpholine by Major Manufacturers
11.2 Production Value of Morpholine by Major Manufacturers
11.3 Basic Information of Morpholine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Morpholine Major Manufacturer
11.3.2 Employees and Revenue Level of Morpholine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MORPHOLINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 APL (IN)
12.1.1 Company profile
12.1.2 Representative Morpholine Product
12.1.3 Morpholine Sales, Revenue, Price and Gross Margin of APL (IN)
12.2 Anhui Haoyuan (CN)
12.2.1 Company profile
12.2.2 Representative Morpholine Product
12.2.3 Morpholine Sales, Revenue, Price and Gross Margin of Anhui Haoyuan (CN)
12.3 FUYUAN (CN)
12.3.1 Company profile
12.3.2 Representative Morpholine Product
12.3.3 Morpholine Sales, Revenue, Price and Gross Margin of FUYUAN (CN)
12.4 Liaoyuan (CN)
12.4.1 Company profile
12.4.2 Representative Morpholine Product
12.4.3 Morpholine Sales, Revenue, Price and Gross Margin of Liaoyuan (CN)
12.5 Sinochem (CN)
12.5.1 Company profile
12.5.2 Representative Morpholine Product
12.5.3 Morpholine Sales, Revenue, Price and Gross Margin of Sinochem (CN)
12.6 Huntsman (US)
12.6.1 Company profile
12.6.2 Representative Morpholine Product
12.6.3 Morpholine Sales, Revenue, Price and Gross Margin of Huntsman (US)
12.7 Basf (DE)
12.7.1 Company profile
12.7.2 Representative Morpholine Product
12.7.3 Morpholine Sales, Revenue, Price and Gross Margin of Basf (DE)
12.8 Nippon Nyukazai (JP)
12.8.1 Company profile
12.8.2 Representative Morpholine Product
12.8.3 Morpholine Sales, Revenue, Price and Gross Margin of Nippon Nyukazai (JP)
12.9 Balaji Amines (IN)
12.9.1 Company profile
12.9.2 Representative Morpholine Product
12.9.3 Morpholine Sales, Revenue, Price and Gross Margin of Balaji Amines (IN)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MORPHOLINE
13.1 Industry Chain of Morpholine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MORPHOLINE
14.1 Cost Structure Analysis of Morpholine
14.2 Raw Materials Cost Analysis of Morpholine
14.3 Labor Cost Analysis of Morpholine
14.4 Manufacturing Expenses Analysis of Morpholine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Morpholine in This Report
1.2 Commercial Types of Morpholine
1.2.1 Purity 97%
1.2.2 Purity 98%
1.2.3 Purity 98.5%
1.2.4 Other
1.3 Downstream Application of Morpholine
1.3.1 Chemical Reagents
1.3.2 Pharmaceutical Intermediates
1.3.3 Other
1.4 Development History of Morpholine
1.5 Market Status and Trend of Morpholine 2013-2023
1.5.1 Global Morpholine Market Status and Trend 2013-2023
1.5.2 Regional Morpholine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Morpholine 2013-2017
2.2 Sales Market of Morpholine by Regions
2.2.1 Sales Volume of Morpholine by Regions
2.2.2 Sales Value of Morpholine by Regions
2.3 Production Market of Morpholine by Regions
2.4 Global Market Forecast of Morpholine 2018-2023
2.4.1 Global Market Forecast of Morpholine 2018-2023
2.4.2 Market Forecast of Morpholine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Morpholine by Types
3.2 Sales Value of Morpholine by Types
3.3 Market Forecast of Morpholine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Morpholine by Downstream Industry
4.2 Global Market Forecast of Morpholine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Morpholine Market Status by Countries
5.1.1 North America Morpholine Sales by Countries (2013-2017)
5.1.2 North America Morpholine Revenue by Countries (2013-2017)
5.1.3 United States Morpholine Market Status (2013-2017)
5.1.4 Canada Morpholine Market Status (2013-2017)
5.1.5 Mexico Morpholine Market Status (2013-2017)
5.2 North America Morpholine Market Status by Manufacturers
5.3 North America Morpholine Market Status by Type (2013-2017)
5.3.1 North America Morpholine Sales by Type (2013-2017)
5.3.2 North America Morpholine Revenue by Type (2013-2017)
5.4 North America Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Morpholine Market Status by Countries
6.1.1 Europe Morpholine Sales by Countries (2013-2017)
6.1.2 Europe Morpholine Revenue by Countries (2013-2017)
6.1.3 Germany Morpholine Market Status (2013-2017)
6.1.4 UK Morpholine Market Status (2013-2017)
6.1.5 France Morpholine Market Status (2013-2017)
6.1.6 Italy Morpholine Market Status (2013-2017)
6.1.7 Russia Morpholine Market Status (2013-2017)
6.1.8 Spain Morpholine Market Status (2013-2017)
6.1.9 Benelux Morpholine Market Status (2013-2017)
6.2 Europe Morpholine Market Status by Manufacturers
6.3 Europe Morpholine Market Status by Type (2013-2017)
6.3.1 Europe Morpholine Sales by Type (2013-2017)
6.3.2 Europe Morpholine Revenue by Type (2013-2017)
6.4 Europe Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Morpholine Market Status by Countries
7.1.1 Asia Pacific Morpholine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Morpholine Revenue by Countries (2013-2017)
7.1.3 China Morpholine Market Status (2013-2017)
7.1.4 Japan Morpholine Market Status (2013-2017)
7.1.5 India Morpholine Market Status (2013-2017)
7.1.6 Southeast Asia Morpholine Market Status (2013-2017)
7.1.7 Australia Morpholine Market Status (2013-2017)
7.2 Asia Pacific Morpholine Market Status by Manufacturers
7.3 Asia Pacific Morpholine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Morpholine Sales by Type (2013-2017)
7.3.2 Asia Pacific Morpholine Revenue by Type (2013-2017)
7.4 Asia Pacific Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Morpholine Market Status by Countries
8.1.1 Latin America Morpholine Sales by Countries (2013-2017)
8.1.2 Latin America Morpholine Revenue by Countries (2013-2017)
8.1.3 Brazil Morpholine Market Status (2013-2017)
8.1.4 Argentina Morpholine Market Status (2013-2017)
8.1.5 Colombia Morpholine Market Status (2013-2017)
8.2 Latin America Morpholine Market Status by Manufacturers
8.3 Latin America Morpholine Market Status by Type (2013-2017)
8.3.1 Latin America Morpholine Sales by Type (2013-2017)
8.3.2 Latin America Morpholine Revenue by Type (2013-2017)
8.4 Latin America Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Morpholine Market Status by Countries
9.1.1 Middle East and Africa Morpholine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Morpholine Revenue by Countries (2013-2017)
9.1.3 Middle East Morpholine Market Status (2013-2017)
9.1.4 Africa Morpholine Market Status (2013-2017)
9.2 Middle East and Africa Morpholine Market Status by Manufacturers
9.3 Middle East and Africa Morpholine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Morpholine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Morpholine Revenue by Type (2013-2017)
9.4 Middle East and Africa Morpholine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF MORPHOLINE
10.1 Global Economy Situation and Trend Overview
10.2 Morpholine Downstream Industry Situation and Trend Overview
CHAPTER 11 MORPHOLINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Morpholine by Major Manufacturers
11.2 Production Value of Morpholine by Major Manufacturers
11.3 Basic Information of Morpholine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Morpholine Major Manufacturer
11.3.2 Employees and Revenue Level of Morpholine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 MORPHOLINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 APL (IN)
12.1.1 Company profile
12.1.2 Representative Morpholine Product
12.1.3 Morpholine Sales, Revenue, Price and Gross Margin of APL (IN)
12.2 Anhui Haoyuan (CN)
12.2.1 Company profile
12.2.2 Representative Morpholine Product
12.2.3 Morpholine Sales, Revenue, Price and Gross Margin of Anhui Haoyuan (CN)
12.3 FUYUAN (CN)
12.3.1 Company profile
12.3.2 Representative Morpholine Product
12.3.3 Morpholine Sales, Revenue, Price and Gross Margin of FUYUAN (CN)
12.4 Liaoyuan (CN)
12.4.1 Company profile
12.4.2 Representative Morpholine Product
12.4.3 Morpholine Sales, Revenue, Price and Gross Margin of Liaoyuan (CN)
12.5 Sinochem (CN)
12.5.1 Company profile
12.5.2 Representative Morpholine Product
12.5.3 Morpholine Sales, Revenue, Price and Gross Margin of Sinochem (CN)
12.6 Huntsman (US)
12.6.1 Company profile
12.6.2 Representative Morpholine Product
12.6.3 Morpholine Sales, Revenue, Price and Gross Margin of Huntsman (US)
12.7 Basf (DE)
12.7.1 Company profile
12.7.2 Representative Morpholine Product
12.7.3 Morpholine Sales, Revenue, Price and Gross Margin of Basf (DE)
12.8 Nippon Nyukazai (JP)
12.8.1 Company profile
12.8.2 Representative Morpholine Product
12.8.3 Morpholine Sales, Revenue, Price and Gross Margin of Nippon Nyukazai (JP)
12.9 Balaji Amines (IN)
12.9.1 Company profile
12.9.2 Representative Morpholine Product
12.9.3 Morpholine Sales, Revenue, Price and Gross Margin of Balaji Amines (IN)
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MORPHOLINE
13.1 Industry Chain of Morpholine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF MORPHOLINE
14.1 Cost Structure Analysis of Morpholine
14.2 Raw Materials Cost Analysis of Morpholine
14.3 Labor Cost Analysis of Morpholine
14.4 Manufacturing Expenses Analysis of Morpholine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
